Susan Benton - Net Worth and Insider Trading
Susan Benton Net Worth
The estimated net worth of Susan Benton is at least $34,765 dollars as of 2024-09-20. Susan Benton is the Director of Ocuphire Pharma Inc and owns about 23,976 shares of Ocuphire Pharma Inc (OCUP) stock worth over $34,765. Details can be seen in Susan Benton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Susan Benton has not made any transactions after 2021-09-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Susan Benton
Susan Benton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Susan Benton owns 1 companies in total, including Ocuphire Pharma Inc (OCUP) .
Click here to see the complete history of Susan Benton’s form 4 insider trades.
Insider Ownership Summary of Susan Benton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OCUP | Ocuphire Pharma Inc | 2021-09-02 | director |
Susan Benton Latest Holdings Summary
Susan Benton currently owns a total of 1 stock. Susan Benton owns 23,976 shares of Ocuphire Pharma Inc (OCUP) as of September 2, 2021, with a value of $34,765.
Latest Holdings of Susan Benton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OCUP | Ocuphire Pharma Inc | 2021-09-02 | 23,976 | 1.45 | 34,765 |
Holding Weightings of Susan Benton
Susan Benton Form 4 Trading Tracker
According to the SEC Form 4 filings, Susan Benton has made a total of 1 transactions in Ocuphire Pharma Inc (OCUP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Ocuphire Pharma Inc is the acquisition of 20,000 shares on September 2, 2021, which cost Susan Benton around $91,400.
Insider Trading History of Susan Benton
- 1
Susan Benton Trading Performance
GuruFocus tracks the stock performance after each of Susan Benton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Susan Benton is -17.94%. GuruFocus also compares Susan Benton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Susan Benton within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Susan Benton's insider trading performs compared to the benchmark.
Performance of Susan Benton
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.57 | | | | | |
| Relative Return to S&P 500(%) | 17.54 | | | | | |
Susan Benton Ownership Network
Susan Benton Owned Company Details
What does Ocuphire Pharma Inc do?
Who are the key executives at Ocuphire Pharma Inc?
Susan Benton is the director of Ocuphire Pharma Inc. Other key executives at Ocuphire Pharma Inc include Chief Executive Officer George Magrath , SVP & Operations & Bus. Dev. Ronil A. Patel , and director & President and CEO Mina Sooch .
Ocuphire Pharma Inc (OCUP) Insider Trades Summary
Over the past 18 months, Susan Benton made no insider transaction in Ocuphire Pharma Inc (OCUP). Other recent insider transactions involving Ocuphire Pharma Inc (OCUP) include a net purchase of 30,000 shares made by George Magrath , and a net purchase of 2,000 shares made by .
In summary, during the past 3 months, insiders sold 0 shares of Ocuphire Pharma Inc (OCUP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocuphire Pharma Inc (OCUP) were sold and 45,500 shares were bought by its insiders, resulting in a net purchase of 45,500 shares.
Ocuphire Pharma Inc (OCUP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocuphire Pharma Inc Insider Transactions
Susan Benton Mailing Address
Above is the net worth, insider trading, and ownership report for Susan Benton. You might contact Susan Benton via mailing address: 3916 Valrico Grove Drive, Valrico Fl 33594.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
